Skip to main content
. 2019 May 20;8(5):713. doi: 10.3390/jcm8050713

Table 3.

Outcomes in kidney transplant donors and recipients.

Donors Control Group (n = 85) RIPC Group (n = 85) p-Value
Progression to chronic kidney disease, n (%) 6 (7.1) 8 (9.4) 0.78
Proportion with sCr ≥ 1.4 mg/dL at discharge, n (%) 17 (20.0) 6 (7.1) <0.05
Recipients Control Group (n = 83) Treated Group (n = 85) p-Value
Time to 50% decrease in sCr, days 1.1 ± 0.6 1.4 ± 3.2 0.58
Delayed graft function, n (%) 0 (0.0) 2 (2.4) 0.49
Acute rejection, n (%) 5 (6.0) 5 (5.9) 1.00
Graft failure, n (%) 1 (1.2) 0 (0.0) 0.99
eGFR at discharge, mL/min/1.73 m2 87.9 ± 17.7 83.9 ± 19.4 0.18
Mean difference 1 −3.23 (−8.62–2.16) 0.14
eGFR at postoperative 1 year, mL/min/1.73 m2 77.0 ± 24.5 79.5 ± 18.2 0.49
Mean difference 1 3.45 (−3.11–10.01) 0.29

RIPC, remote ischemic preconditioning; sCr, serum creatinine; eGFR, estimated glomerular filtration rate. eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. 1 Difference in means (95% CI) adjusted for warm ischemic time and preoperative serum creatinine, age and baseline eGFR of donor.